Defining the circuits and the roles of neuronal classes that produce movements is critical; both for a basic understanding of how the nervous system works and, as importantly, for understanding what goes wrong in the various medical conditions affecting normal movement. In 2022, The Brain Prize – the world’s largest brain research prize – was awarded to Silvia Arber, Martyn Goulding and Ole Kiehn for having revolutionized our understanding of the cells and circuits underlying mammalian body movement.

Neurotorium and The Brain Prize collaborate on making this exceptional research available to clinicians who are working with matters of the brain in their daily lives.

In this documentary film, developed by the team behind The Brain Prize at the Lundbeck Foundation, you can learn more about how we mammalians move and the research that led to the brain prize in 2022. Patients who suffer from Parkinson’s Disease experience first-hand the consequences of motor circuit dysfunction.

Related content

image Image Graphic showing extracellular, multimerization, and intracellular targets of alpha-synuclein for therapeutic intervention in Parkinson’s disease
Possible α-synuclein targets for development of therapies for Parkinson’s disease

Overview of three therapeutic strategies targeting alpha-synuclein in the development of disease-modifying treatments for Parkinson’s disease

26.06.2025 Parkinson’s Disease
image Image Chart showing progression of functional decline in Parkinson’s disease with different treatment approaches, from symptomatic benefit to disease modification.
Disease modification in Parkinson’s disease

Graphical representation of how various treatment strategies can impact disease progression in Parkinson’s disease, from symptom relief to potential cure

26.06.2025 Parkinson’s Disease
image Image Diagram showing how COMT inhibitors block the conversion of L-DOPA to 3-OMD, enhancing dopamine levels in the synapse in Parkinson’s disease.
Catechol-O-methyltransferase (COMT) inhibitors mechanism of action

Illustration of how COMT inhibitors increase dopamine availability in Parkinson’s disease by preventing the breakdown of L-DOPA

26.06.2025 Parkinson’s Disease